BRANDY NOKES: Open Payments
NPI 1457873150 · MORRISON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,574 in 78 payments from 11 companies in 2025. Trend: 2023 $927 · 2024 $720 · 2025 $1,574
Food & beverage: $1,574
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $265 |
| Vanda Pharmaceuticals Inc. | 8 | $241 |
| Otsuka America Pharmaceutical, Inc. | 13 | $198 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $186 |
| Teva Pharmaceuticals USA, Inc. | 7 | $161 |
| E.R. Squibb & Sons, L.L.C. | 7 | $157 |
| Neurocrine BioSciences, Inc. | 7 | $151 |
| ABBVIE INC. | 9 | $137 |
| Lundbeck LLC | 2 | $40 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
Products named: FANAPT, CAPLYTA, REXULTI, UZEDY, COBENFY, INGREZZA, ARISTADA, VRAYLAR.
Industry payments across TN — which companies pay providers there.
